Thus far, Actemra® (tocilizumab) is used to treat children with systemic-onset JIA.
Ukuza kuthi ga ngoku iActemra® (tocilizumab) isetyenziselwa ukunyanga abantwana abanesifo sokuqaqamba kwamalungu omzimba wonke.